stockmarketproxy
/
UTHRNasdaq SEC EDGAR

UNITED THERAPEUTICS Corp

Pharmaceutical Preparations·SILVER SPRING, MD·FY end 12/31·CIK 1082554
OverviewFinancialsCompensationGovernanceInsidersFilings

Board of Directors

13 members · 12 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
Christopher CauseyDirector21y63NCGAudit
Richard GiltnerDirector15y62AuditNCG
Ray KurzweilDirector22y78
Jan MalcolmDirector0y70Audit
Linda MaxwellDirector4y52CompNCG
Nilda MesaDirector6y66CompNCG
Judy OlianDirector9y74Audit
Christopher PatuskyLead Independent Director22y62CompNCG
Martine RothblattChair28y71
Louis SullivanDirector22y92Comp
Tommy ThompsonDirector14y84Audit
Kevin TraceyDirector0y68
Raymond DwekDirectorComp

Risk-factor diff

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.